Azienda USL di Modena, Italy

Time frame: 1 December 2022 - 30 November 2023

Profile

The positions in the table below reflect the Azienda USL di Modena's position overall, domestically, within their sector, and in various subject areas based on their Share. Each position links to the corresponding table where Azienda USL di Modena is listed.

Position by research output Share

Global Italy
Overall 6833 301
Healthcare 2405 138

Position by research output Share in subject areas

Global Italy
Biological sciences 3379 145

Research

Overall research output

Count Share
Overall 1 0.05

Overall Count and Share for 'Azienda USL di Modena' based on the 12-month time frame mentioned above.

View all articles

Research outputs by subject area

Subject Count Share
Biological sciences 1 0.05

Note: Articles may be assigned to more than one subject area. Hover over the donut graph to view the Share for each subject.

Share output for the past 5 years

Compare with other institutions

Nature Strategy Reports

Identify research insights to guide research strategy and grow your impact with our Nature Strategy reports.

  1. Actionable insights into research performance.

  2. Detailed analysis of strengths and weaknesses.

  3. Covers all major disciplines and regions of the world.

Nature Navigator

Data-driven insights for informed research strategy decisions with AI summarisation technology.

  1. Track trends, summarise articles effortlessly.

  2. Spark serendipitous discoveries.

  3. Uncover collaboration opportunities.

Collaboration

International vs domestic collaboration by Share

Type Percentage
International (1 institutions) 23.1%
Domestic (6 institutions) 76.9%

Note: Hover over the graph to view the percentage of collaboration.

Top 5 domestic collaborators with Azienda USL di Modena by Share

Collaborating institutions

Share

Top 5 international collaborators with Azienda USL di Modena by Share

Collaborating institutions

Share

  • Advertisement

Latest supplement

Nature Index 2024 Health Sciences

More money is being spent on medical R&D than ever before, but with few new drugs to show for it. The race is on to find technological solutions that will speed up drug development and deliver better clinical outcomes. Nature Index Health Sciences 2024 highlights the people and projects that are bringing fresh perspectives to some of the most complex challenges in medicine and provides an in-depth look at how one country – the United States – is dominating the field.

Nature Index 2024 Health Sciences